Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Daily Feed
  • Analyst Insights & IR
  • Disclosures
    • Semiconductors
    • Energy
    • Robotics
    • Bio & Healthcare
  • Toggle search form

[Disclosure] Alteogen (196170) to List 52,500 Additional Shares Following Stock Option Exercises

Posted on May 13, 2026July 10, 2026 By K-STOCK Editor No Comments on [Disclosure] Alteogen (196170) to List 52,500 Additional Shares Following Stock Option Exercises

Source Fact: Financial Supervisory Service DART / 2026-05-13

Disclosure Type: Additional Listing (Exercise of Stock Options)

💡 3-Second Summary

Alteogen will list an additional 52,500 common shares on May 18, 2026, following the exercise of employee stock options. The exercise price per share is KRW 37,900.

📊 1. [Key Disclosure Details & Figures Summary]

  • Type & Number of Additional Shares: 52,500 common shares
  • Reason for Listing: Exercise of employee stock options (118th issuance, exercised on May 4, 2026)
  • Exercise Price per Share: KRW 37,900
  • Listing Date: May 18, 2026
  • Total Outstanding Shares After Listing: Common shares will increase to a total of 53,586,343 shares
  • Par Value per Share: KRW 500

📈 2. [Expert Insight: Stock Price Impact Analysis]

  • Negligible Dilution, Limited Overhang Risk: The 52,500 additional shares represent only about 0.098% of Alteogen’s total outstanding shares (approx. 53.58 million shares). Because the dilution profile is well under 0.1%, any downward pressure on the stock price due to sudden market oversupply will be practically non-existent.
  • Potential for Short-Term Profit-Taking: With the exercise price set at KRW 37,900, the option holders are highly likely sitting on substantial valuation gains relative to the current market price. Consequently, some of these shares may hit the open market around the listing date (May 18) for profit-taking, but the volume is too small to cause anything more than minor, transient volatility.
  • Neutral Event Detached from Corporate Fundamental: This additional listing is a routine corporate event executing pre-agreed employee compensation, rather than a reflection of any degradation in Alteogen’s pipeline or business operations. It should be treated as a neutral disclosure with no structural impact on the mid-to-long-term stock trend.

📝 Editor’s Comment (by K-STOCK Editor)

While stock option exercise disclosures occasionally trigger overhang anxieties when the gap between the market price and the exercise price is wide, there is absolutely no reason to panic here. The volume hitting the market constitutes less than 0.1% of Alteogen’s total equity. Investors should simply log May 18 in their diaries as a day where a small pocket of profit-taking might occur, without worrying about any structural threat to their investment thesis.

📢 Disclaimer & Source Information

Source: This content was structured and generated based on the official data submitted to the Financial Supervisory Service electronic disclosure system (DART).

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] SK square (402340) Subsidiary SK hynix Announces $10.4M Treasury Stock Disposal, But Actual Immediate Volume is Just “191 Shares”?
Next Post: [Disclosure] Daeduck Electronics (353200) Issued Trading Suspension Preview Amid Overheating Alert

Related Posts

[Disclosure] Alteogen (196170) to Host Domestic IR in Yeouido, Signaling Major Updates on Bio Platform & Pipelines Disclosures
[Disclosure] Alteogen (196170) to Host AGM on Mar 31: Approving KRW 20B Dividend & Establishing Audit Committee Disclosures
[Disclosure] Alteogen (196170) Reports Q1 2026 Operating Profit of KRW 39.3B… An Explosive 100% QoQ Surge Disclosures
[Disclosure] Alteogen (196170) Approves KRW 215.8B Revenue & First-Ever KRW 20B Cash Dividend at Annual Shareholders Meeting Disclosures
[Disclosure] Alteogen (196170) to Hold Overseas IR Hosted by Bank of America, Targeting Global Institutional Investors Disclosures
[Disclosure] Alteogen (196170) Reports FY2025 Operating Profit of KRW 106.9B, Surging 320.8% YoY Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hana Micron (067310) Lifted from Investment Warning Stock Status; Reclassified to Investment Caution on June 9 with Re-designation WarningJuly 8, 2026
  • [Discount Reversal via ADR Listing and Entry into an HBM-Led Super Cycle: SK hynix 000660]July 7, 2026
  • [Discount Narrowing via ADR Listing Momentum and Capital Allocation Diversification: SK Square 402340]July 7, 2026
  • Gaon Cable (000500): Structural Re-rating Driven by North American Infrastructure Expansion and AI Data Center Demand ShocksJuly 7, 2026
  • Hugel (145020): Passing the Trough with Q2 Earnings Surprise and Accelerated U.S. Direct Sales DeploymentJuly 7, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme